EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 2)
EnCoRe MoMS Aim 2: Engaging Communities to Reduce Morbidity From Maternal Sepsis
2 other identifiers
observational
400,000
1 country
1
Brief Summary
Sepsis is the second leading cause of maternal death in the U.S. For racial and ethnic minoritized birthing people, especially those who are Black, living in poverty, and from underserved communities, labor and postpartum are particularly vulnerable risk periods. The goal of this multi-center, multidisciplinary observational study is to optimize risk prediction accounting for the social determinants of health, and establish a novel maternal care continuity model to reduce sepsis- related death and disability and increase maternal health equity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 26, 2023
CompletedFirst Submitted
Initial submission to the registry
November 20, 2023
CompletedFirst Posted
Study publicly available on registry
November 28, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 9, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2026
ExpectedJanuary 21, 2026
January 1, 2026
2.6 years
November 20, 2023
January 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Maternal sepsis risk
Sepsis as evaluated by the following scoring systems: Sepsis-2 (proven or suspected infection in combination with at least two systemic inflammatory response syndrome criteria); Sepsis-3 (organ dysfunction as defined by an acute change in total organ dysfunction score within 24 hours of suspected infection); and Center for Disease Control (CDC) Sepsis (presumed infection and organ dysfunction based on CDC criteria).
Delivery hospitalization through 8 weeks postpartum
Study Arms (1)
PRC Database
EHR records for hospital delivery admissions and postpartum readmissions obtained from Perinatal Research Consortium (PRC) sites to be harmonized with SDoH data and analyze to optimize sepsis risk prediction.
Eligibility Criteria
Delivery admission records at PRC sites
You may qualify if:
- Be 18 years or older
- Delivery admission (and) postpartum readmission at one of the Perinatal Research Consortium sites 2014-2021
You may not qualify if:
- Under 18 years old
- Delivery admission (and) postpartum readmission at hospital that is not in the Perinatal Research Consortium
- Delivery admission before 2014 or after 2021
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Columbia Unviersity Medical Center
New York, New York, 10032, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dena Goffman, MD
Columbia University
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ellen Jacobson Levine and Eugene Jacobson Professor of Women's Health (in Obstetrics and Gynecology)
Study Record Dates
First Submitted
November 20, 2023
First Posted
November 28, 2023
Study Start
April 26, 2023
Primary Completion
December 9, 2025
Study Completion (Estimated)
September 30, 2026
Last Updated
January 21, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share